Dot Compliance provides a ready-to-use, AI-enabled quality management system built on the Salesforce.com platform. Its suite includes an extensive set of off-the-shelf QMS and compliance pre-configured practice processes, enabling customers to deploy quickly and cost effectively. The solutions are used by life sciences companies both large and small and are fully compliant with 21 CFR part 11, EU-Annex 11 and support ISO 9001, 13485, 14791 and 27001. Led by founder and CEO Doron Sitbon, the company says it is transforming into a data company and aims to create a new category of AI-driven compliance. It plans to use the new funding to accelerate its AI software solutions, drive continued product innovation and customer acquisition, and meet escalating market demand. The Series B extension increased the company’s total raised to $50M. Dot Compliance provides a Quality Management System built on the Salesforce.com platform, offering an off-the-shelf suite of pre-configured QMS and compliance best-practice processes that customers can deploy quickly and cost-effectively. Its Dot Compliance Suite supports regulatory and quality standards including full compliance with 21 CFR part 11 and EU‑Annex 11 and support for ISO 9001, 13485, 14791 and 27001. The company’s solutions are used by life sciences companies worldwide and serve more than 200,000 users. Dot Compliance intends to use the new funds to drive business expansion and further develop its quality and compliance solutions for pharmaceutical and medical device companies. The company was founded in 2015 by Doron Sitbon and operates from Phoenix, AZ and Rehovot, Israel.

Total raised

$41M

Funding rounds

2

Latest round

Series B

Latest activity

Apr 2024